FDA inspection
Bausch Health Companies Inc.: FDA inspection ending Feb 17, 2017
FDA inspection 1007199 · No Action Indicated (NAI) · Laval
Key facts
| Inspection ID | 1007199 |
|---|---|
| Firm | Bausch Health Companies Inc. |
| FEI number | 3002807186 |
| Address | 2150 Saint-Elzear Blvd W |
| City | Laval |
| Country | Canada |
| Fiscal year | 2017 |
| Inspection end date | Feb 17, 2017 |
| Classification | No Action Indicated (NAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- No Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data